FDA Inspection 547946 — Astellas Pharma US Inc.

Astellas Pharma US Inc. — FEI 1000036852

The FDA completed an inspection of Astellas Pharma US Inc. on Nov 20, 2008 in Northbrook, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 20, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Northbrook, IL (United States)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.